Citadel Advisors »

Aptose Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Aptose Biosciences (APTO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Aptose Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Aptose Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aptose Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $43k 26k 1.66
2023-12-31 $155k 62k 2.51
2023-09-30 $49k 17k 2.80

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Aptose Biosciences

DRW Holdings
Sigma Planning
Nantahala Capital Management
Morgan Stanley
Citadel Advisors
Texas Capital Bank Wealth Management Services
PDS Planning
TD Waterhouse Canada
Us Bancorp
Royal Bank of Canada
Gleason Group
Newbridge Financial Services Group
Advisor Group Holdings
HighMark Wealth Management
Beaird Harris Wealth Management

View all funds holding Aptose Biosciences